USPTO serial 79263331
AXXELENT
Reviewed by CopyMark Law Group
Reg. 6010415Status 706Registered
- Filing date
- Status date
- Registration date
- Mar 17, 2020
- Examiner
- ELTON, DAVID JONATHAN
- Law office
- Historical data usage
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with AXXELENT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Louis J. Levy
Louis J. Levy Symbus Law Group PLLC1775 I Street, NW, Suite 1150Washington, DC 20006United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medicinal and pharmaceutical preparations for use in the syndromic approach for treating [ pain, headache, fever, coughs, shock, dehydration, hypoglycemia, oral and dental conditions, gastrointensal conditions, respiratory disease, obstetrical/gynecological conditions, ] cardiovascular disease [ , skin diseases, allergic reactions, musculo-skeletal and joint diseases, kidney and urological disorders, otolaryngological diseases, eye diseases, neurological system diseases, metabolic and endocrinological diseases, hematological diseases, malignant diseases, protozoal infections and conditions, sexually transmitted infections, HIV and other viral infections, nutritional disorders and poisoning; pharmaceutical preparations, namely, contraceptive preparations ] | ACTIVE | — |
| 042 | Scientific and medical research and development in the fields of medicines, diagnostic aids and radio-pharmaceuticals for the treatment of pain, headaches, fevers, coughs, shock, dehydration, hypoglycemia, oral and dental conditions, gastrointestinal conditions, respiratory conditions, obstetrical/gynecological conditions and contraception, cardiovascular conditions, skin diseases and allergic reactions, musculo-skeletal and joint conditions, kidney and urological disorders, otolaryngological disearcehs, eye conditions, neurological conditions, metabolic and endorcinological conditions, hematolical conditions, trauma and injuries, malignant disease conditions, malaria, tuberculosis, leprosy, sexually transmitted infections, HIV and other viral infections and conditions, protozoa infections and conditions, poisoning; medical research laboratory services; providing medical and veterinary research information in relation to all of the above; providing medical and scientific research information in the field of pharmaceuticals | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 3, 2026 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Mar 3, 2026 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Feb 23, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Oct 16, 2025 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Mar 17, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Sep 8, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 8, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 8, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 14, 2020 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 29, 2020 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 28, 2020 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jun 17, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 17, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 4, 2020 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Dec 31, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 31, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 18, 2019 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 18, 2019 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Dec 11, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 21, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 21, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 21, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 21, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 21, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 29, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 29, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 28, 2019 | ALIE | ASSIGNED TO LIE | — |
| Oct 23, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 1, 2019 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 1, 2019 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 6, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 19, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 19, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 28, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 27, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 24, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 20, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 20, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 18, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |